Skip to main content

Bipolar Disorders

January 08, 2021
The 6-item Rapid Mood Screener outperformed the Mood Disorder Questionnaire in differentiating bipolar I disorder from major depressive disorder, according to a study published online in Current Medical Research and Opinion.
January 08, 2021
A new study finds that decreased activation of the LEF1 gene in patients with bipolar disorder (BD) could be a useful biomarker for lithium nonresponsiveness, streamlining treatment.
January 08, 2021
After receiving a diagnosis, many patients are brimming with questions. Help your patients find accurate and trustworthy information with this handout.
January 04, 2021
The US Food and Drug Administration (FDA) has accepted Alkermes’ resubmission of the New Drug Application for ALKS 3831, a combination of olanzapine and samidorphan, the company announced.
December 17, 2020
Explore some of the resources on the recently launched NP Psych Navigator platform, which connects nurse practitioners with tools to help them identify mental illness and care for affected patients and their families.
December 08, 2020
Help your patients with bipolar disorder learn more about treatment options with this handout, which describes how medication and talk therapy work.
November 16, 2020
A large community-based pragmatic clinical trial was able to maintain follow-up visit completion rates during the COVID-19 pandemic using telepsychiatry and other virtual tools.
October 26, 2020
Combining medication with psychoeducational therapy, especially in a family or group format, is more effective at preventing episode recurrence in adults and adolescents with bipolar disorder than medication alone, researchers report.
October 13, 2020
Two advisory committees appointed by the US Food and Drug Administration (FDA) have voted in favor of ALKS 3831, a combination of olanzapine and the novel molecular entity samidorphan, Alkermes announced.
Back to Top